摘要:
Provided are systems for applying a polymer fiber matrix to a tubular conduit to create a graft device. The system comprises a polymer solution comprising at least one polymer and at least one solvent; a polymer delivery assembly constructed and arranged to receive the polymer solution and to deliver the polymer fiber matrix to the tubular conduit; a rotating assembly constructed and arranged to rotate at least one of the tubular conduit or the polymer delivery assembly; and a controller constructed and arranged to control the polymer delivery assembly and the rotating assembly. The system is constructed and arranged to reduce the amount of the solvent in the graft device. Methods of applying a polymer fiber matrix with reduced solvent are also provided.
摘要:
Bioremodelable tissue prostheses having a vasculature that is infused with a biomaterial composition. The present invention is directed to casted constructs for treating, reconstructing or replacing damaged or diseased biological tissue. In a preferred embodiment, the casted constructs comprise an ECM member having a biomaterial composition disposed within the vasculature of the ECM member. In some embodiments of the invention, the casted constructs comprise a seamless ECM material derived from a mammalian tissue source. According to the invention, the seamless ECM material can be derived from various mammalian tissue sources, including, without limitation, small intestine, large intestine and umbilical cord.
摘要:
The present invention provides anti-thrombogenic compositions, including anti-thrombogenic vascular grafts. In certain embodiments, the compositions comprise decellularized tissue coated with an anti-thrombogenic coating. The present invention also provides methods of preparing anti-thrombogenic compositions and methods of treatment comprising implanting the anti-thrombogenic compositions into a subject in need thereof.
摘要:
A valved conduit including a bioprosthetic valve, such as a heart valve, and a tubular conduit sealed with a bioresorbable material. The bioprosthetic heart valve includes prosthetic tissue that has been treated such that the tissue may be stored dry for extended periods without degradation of functionality of the valve. The bioprosthetic heart valve may have separate bovine pericardial leaflets or a whole porcine valve. The sealed conduit includes a tubular matrix impregnated with a bioresorbable medium such as gelatin or collagen. The valved conduit is stored dry in packaging in which a desiccant pouch is supplied having a capacity for absorbing moisture within the packaging limited to avoid drying the bioprosthetic tissue out beyond a point where its ability to function in the bioprosthetic heart valve is compromised. The heart valve may be sewn within the sealed conduit or coupled thereto with a snap-fit connection.
摘要:
A two-piece prosthetic valve having first and second members, a first end of the first member being sized and configured to receive a second end of the second member therein, the second end of the second member being attached to the first member at at least one commissure connection point to form at least one leaflet therein.
摘要:
Provided are methods and compositions for constructing stable mammalian epithelial and/or endothelial tissues and organs. Disclosed are methods of using active epithelial and/or endothelial growth factors having the capability of effectuating induction of growth and morphogenesis of cells.
摘要:
A surgically implantable containment member for maintaining a bone augmentation material in a desired location and/or configuration following implantation in a human or other mammalian patient, in which the containment member is made of a natural membrane, such as pericardium, isolated from an animal donor and processed to avoid inflammation or tissue rejection, and a method of bone augmentation using such a containment member. In a particularly preferred embodiment, the containment member has a window which rapidly dissipates upon exposure to bodily fluids after implantation to expose bone augmentation material contained within the containment member to an adjacent bone to be augmented.
摘要:
Die vorliegende Erfindung betrifft ein medizinisches Produkt (100), insbesondere zur Anwendung bei der Behandlung, insbesondere regenerativen Behandlung, von Knorpelschäden und/oder -defekten, umfassend eine schaumartige Komponente (110) und eine membranartige Komponente (120) und/oder eine faserförmige Komponente (130). Die vorliegende Erfindung betrifft weiterhin ein Verfahren zur Herstellung eines medizinischen Produktes, bei welchem ein Treibmittel enthaltendes Reaktionsgemisch für eine schaumartige Komponente in Gegenwart einer membranartigen Komponente und vorzugsweise einer faserförmigen Komponente aufschäumen gelassen wird.